ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
135,488,140
Total 13F shares
66,549,683
Share change
-523,769
Total reported value
$4,154,048,742
Put/Call ratio
67%
Price per share
$62.43
Number of holders
282
Value change
-$66,618,101
Number of buys
133
Number of sells
148

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q3 2021

As of 30 Sep 2021, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 282 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 66,549,683 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, JOHNSON & JOHNSON, JPMORGAN CHASE & CO, Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, CREDIT SUISSE AG/, NORTHERN TRUST CORP, and FMR LLC. This page lists 282 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
304
Q3 2021 holders
282
Holder diff
-22
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.